| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $107.5M | +66.9% |
| R&D Expense | $37.4M | -0.6% |
| SG&A Expense | $73.7M | +6.5% |
| Operating Income | -$3.6M | +92.3% |
| Pre-tax Income | $129.2M | +389.7% |
| Income Tax | $23.4M | +97.8% |
| Net Income | $105.9M | +287.7% |
| EPS (Basic) | $2.10 | +282.6% |
| EPS (Diluted) | $2.06 | +279.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $167.8M | +344.0% |
| Current Assets | $418.5M | +159.8% |
| Total Assets | $485.6M | +37.1% |
| Current Liabilities | $38.3M | +19.4% |
| Stockholders' Equity | $296.7M | +69.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $238.5M | +2168.0% |
| Investing Cash Flow | -$105.3M | -957.1% |
| Financing Cash Flow | -$3.2M | -30.1% |